CHANGZHOU HANGYU PHARMACEUTICAL TECHNOLOGY CO., LTD
Business Type:Lab/Research institutions
Audited Supplier
- Main Products:
- Rapamycin（53123-88-9），Bendazac L-lysine(81919-14-4)，Leflunomide(75706-12-6)，Xanthophyll(127-40-2)，Probenecid(57-66-9)
- Year Established:
- 2011
CHANGZHOU HANGYU PHARMACEUTICAL TECHNOLOGY CO., LTD., founded in 1984, engages in pharmaceutical research, development, production, process design and technical consultation of synthetic pharmaceutical products. The organizational structure includes RD Dept., Quality Inspection Dept., Pilot Plant and Sales Dept., etc. Our pilot plant established 100,000 grade asepsis drug preparation workshop, biological extraction workshop as well as rectification, drying and packaging workshops for synthetic d...
MoreCompany Authentication
Time of verification: | 2015-1-14 10:11 | |
Company Name: | CHANGZHOU HANGYU PHARMACEUTICAL TECHNOLOGY CO., LTD | |
Country/Territory: | China (Mainland) | |
Registered Address: | No.300,Yanling Middle Road, Changzhou, Jiangsu, China | |
Company Scale: |
11 - 50 | |
Registered Capital: |
500000 |
|
Business Type: |
True |
|
Business Scope: |
Rapamycin（53123-88-9），Tacrolimus(104987-11-3), Leflunomide(75706-12-6)，Everolimus(159351-69-6), Pirfenidone（53179-13-8），Nafamostat Mesylate（82956-11-4），Hexadecylpyridinium Chloride Monohydrate（6004-24-6），α-Naphthoflavone（604-59-1） |
|
Main Markets: |
North America Eastern Europe Eastern Asia |
|
Company Corporate Representative: | Xiaxiankun |
Certificate
Business License: |
|
Tax Registration Certificate: |
|
Organization Code Certificate: |
|
Legal person's id card: |